Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Search in:

Advanced search

Journal of Medical Economics Volume 25, 2022 - Issue 1

Submit an article Journal homepage

Open access

2,839

Views

CrossRef citations to date

Altmetric

Respiratory Medicine

Impact of timing of nintedanib initiation among patients newly diagnosed with idiopathic pulmonary fibrosis

David Singera Boehringer Ingelheim, Ridgefield, CT, USA

Lindsay G. S. Bengtsonb Optum, Eden Prairie, MN, USACorrespondence[email protected]

https://orcid.org/0000-0002-5370-4090

Craig S. Conoscentia Boehringer Ingelheim, Ridgefield, CT, USA

Amy J. Andersonb Optum, Eden Prairie, MN, USA

Lee Brekkeb Optum, Eden Prairie, MN, USA

Sharash S. Shettya Boehringer Ingelheim, Ridgefield, CT, USA

Joao de Andradec Vanderbilt University Medical Center, Nashville, TN, USA

show all

Pages 532-540 | Received 10 Jan 2022, Accepted 14 Mar 2022, Published online: 28 Apr 2022

Cite this article
https://doi.org/10.1080/13696998.2022.2054203
CrossMark

Full Article
Figures & data
References
Supplemental
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (2)

Shu Yan, Shuyu Xue, Tiantian Wang, Ruihang Gao, Hanqiao Zeng, Qianmeng Wang & Xiaojing Jia. (2023) Efficacy and safety of nintedanib in patients with non-small cell lung cancer, and novel insights in radiation-induced lung toxicity. Frontiers in Oncology 13.
Crossref

Hongbo Ma, Shengming Liu, Shanrui Li & Yong Xia. (2022) Targeting Growth Factor and Cytokine Pathways to Treat Idiopathic Pulmonary Fibrosis. Frontiers in Pharmacology 13.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references